Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Reverses Course, Allows Some Telework For Reviewers

Apr 11 2025

• By Derrick Gingery

Smiling woman sitting on couch typing on open laptop. — (Evgeny Atamenenko/Shutterstock)

Related Content

Cramped Quarters, Limited Parking And Water Concerns Await US FDA’s Return To Office

Mar 14 2025

US FDA Survives First Day Of Return To In-Office Work, But True Test Upcoming

Mar 17 2025

Updated: US Likely To Lose Its First Approver Advantage After FDA Layoffs

Apr 01 2025

As US FDA Settles Into Teleworking, Will Application Reviews Be Affected?

Mar 24 2020

CBER Staffing Remains Challenging, But Permanent Virtual Work May Help Offset Expected Retirements

Jun 03 2022

US FDA Implementing Hybrid Work Policy In January

Nov 22 2022

Sponsors Still Not Racing To Schedule In-Person Meetings With US FDA

Oct 09 2023

Trump’s US FDA Takeover Similar To Flat Earth Proponents Running NASA, Woodcock Says

Apr 07 2025

Peter Marks Resigns From US FDA, Warns Kennedy Does Not Want Truth On Vaccines

Mar 29 2025

CDER Director Patrizia Cavazzoni Retires; Corrigan-Curay Named Acting Head

Jan 10 2025

Oncology Center Of Excellence Deputy Directors Kluetz, Theoret Join US FDA Exodus

Mar 28 2025

Related Companies

Novavax, Inc.

Additional Topics

Comp OTC Drugs Drug Approval Standards Prescription To OTC Switch FDA United States International Supply Chain Consumer Politics

More from Policy & Regulation

More from Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window